Abbott on track for best day in 2 years after reaffirming forecast amid tariff risks

ReutersApr 16, 2025 4:21 PM

Shares of medical device maker Abbott ABT.N rise 5.4% to $133.05

*ABT is the top performer on the S&P 500 .SPX index on Wednesday

Stock has its best day since April 2023, if gains hold

ABT, in a conference call, says it doesn't expect any tariff impact in Q2

Impact of tariffs is projected to be a few hundred million dollars in 2025 - company

ABT reaffirms its annual profit per share forecast of between $5.05 and $5.25, but beats Q1 earnings estimate

Company says two new manufacturing and R&D investments in Illinois and Texas, totaling $500 million, are projected to go live by the end of 2025

Up to last close, stock up 11.6% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

What Is Intel, and Is Its Stock Still a Worthwhile Investment?

Intel has survived its near-death experience. While it is no longer the undisputed king, it has become the bedrock of the Western semiconductor supply chain. For investors, INTC is now a play on industrial resilience rather than pure high-growth software.

Intel vs. TSM: Which Semiconductor Stock Looks Like the Better Investment?

TradingKey - Intel Corporation (NASDAQ: INTC) and Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) are two companies that play crucial roles in the semiconductor market; however, they each have completely different business models.

Precious Metals May Outlook: After U.S.-Iran Conflict Concerns Eased, Will Funds Flow Back to Gold and Silver?

TradingKey - Since April, the precious metals market has continued the weakness seen in March. Spot gold recorded a cumulative decline of nearly 2% in April, while spot silver briefly fell below the $70 mark.

Is SanDisk the Hidden Gem of the AI Boom in 2026? Discover the Potential Risks and Rewards.

TradingKey - SanDisk (SNDK) now represents not just a name for many consumers, but also an investment play on one of the fastest-growing sectors in technology – Artificial Intelligence.

Azure Growth 40%, AI Revenue 37 Billion: Why Did Microsoft Shares Fall Instead of Rise?

TradingKey - On April 29 (ET), Microsoft (MSFT) released its Q3 FY2026 results after the bell. Both revenue and profit exceeded expectations, with Azure growth returning to 40% and annualized AI revenue surpassing $37 billion. Despite this, shares fell more than 3% in after-hours trading and ended t

Featured Tools